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Chapter 1 Introduction 
 
1.1 Motivation 
A fundamental premise for tissue engineering (TE) is that new functional tissues or 
organs can be generated by culturing cells ex vivo in the appropriate environment to restore 
tissue or organ function.[1, 2] In most cases, the cells require a three dimensional (3D) 
porous matrix or scaffold, which provides a framework for cells to attach, proliferate, and 
differentiate.[3] Commonly held criteria for designing polymer scaffolds are that[4, 5]: the 
scaffolds should be biocompatible, biodegradable, non-cytotoxic, and. high porous; they 
should have a customized shape, proper pore size, and suitable mechanical strength; also 
they should be capable of incorporating biomolecules and subsequent controlled release to 
provide the chemical cues for tissue formation in right configuration and functions.[6]  
Conventional methods of TE scaffold fabrication such as fiber bonding[7], solvent 
casting/salt leaching[8, 9] suffered a predominant restriction on structural control and they 
can’t make scaffold with complicated and reproducible structures.[4] Solid freeform 
fabrication (SFF), processes build structures directly from digital geometrical data without 
a mold, represent attractive tools to prepare 3D scaffolds with customized overall external 
shape and complex internal structure.[10-13]  However, among the expanding number of SFF 
techniques, relatively few are suitable for incorporation of these biomolecules within the 
scaffolds because most of them rely on harsh processing conditions, which will denature 
the highly sensitive biomolecules. For example, biodegradable synthetic polymers such as 
poly(lactic acid-co-glycolic acid) (PLGA) can be used in existing SFF techniques, but they 
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have to be melted at elevated temperatures (e.g. fused deposition modeling or selective 
laser sintering technique) or dissolved in toxic organic solvent (e.g. three dimensional 
printing technique) in order to be processable. SFF processes using aqueous and room 
temperature processing conditions would present a benign environment for incorporation of 
biomolecules, but they are limited to water-soluble polymers or hydrogels that are 
mechanical weak and lack molecular design flexibility. Clearly, SFF techniques offer 
superior control of structure compared to bulk processing, but novel SFF technologies have 
to be developed to overcome the inherent difficulties and limitations in the context of tissue 
engineering. 
In this work, an aqueous, low temperature SFF method for making tissue engineering 
scaffolds by using polymer colloidal gel as feedstock has been developed. Colloidal gel is a 
class of materials consisting of a percolating network of attractive colloidal particles. Since 
the particle network is form by the physical association of the latex particles, when subject 
to shear above a threshold known as the yield stress, this particle network will be disrupted 
to exhibit a low viscosity. Upon removal of shear, the particle network will re-establish 
quickly and return to gel state with high elastic modulus. Thus the unique properties of the 
colloidal gel, pseudoplastic rheology and rapid structure recovery kinetics, facilitate the 
material flowing through fine nozzles as a continuous rod and holds its shape to obtain the 
3D structures by drawing 2D patterns in successive layers. The composition of the colloidal 
particles has little effect on the rheological properties such that the ink design allows the 
exploit of latex particles prepared from mechanically strong but water insoluble synthetic 
polymers to fulfill the structural requirements of the scaffold. The aqueous suspensions can 
also contain dual-purpose dissolved biopolymers to render the scaffolds with bioactive 
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chemistry for cell attachment and proliferation as well as functioning as processing aids for 
manipulating the rheological properties of the ink. Since the scaffold fabrication process 
simply rely on the rheology of the colloidal gels and low temperature coalescence of the 
latex particles, sensitive biomolecules can be incorporated in the interstices of sintered 
colloidal particle networks and subsequently released without denaturation during tissue 
culture for regulating cell behaviors. 
1.2 Thesis Scope 
The main objective of this thesis is to develop an aqueous and low temperature based 
SFF method for fabricating bioactive scaffolds, which can be used in tissue engineering. 
This work mainly focuses on two major aspects: 1) to design colloidal gels with 
appropriate rheological properties based on polymer latex particles and to direct-write 
biocompatible 3D scaffold with predefined porous structures; 2) to develop strategies for 
incorporation of proteins into scaffold without activity loss and confer the scaffold with 
capability of spatial and temporal delivery of proteins. To confirm the validity of the work, 
comprehensive characterizations of scaffold was performed in this work to examine the 
biocompatibility of the scaffold and the bioactivity of the released proteins. Finally, the 
application of this process in fabrication of artificial lymph node was demonstrated. 
1.3 Thesis Organization  
This thesis is divided up into 5 chapters. Chapter 1 states the motivation of this work, 
thesis scope, and thesis organization. Chapter 2 is a literature survey pertinent to four inter-
disciplinary fields: polymer latex, freeforming of polymers, tissue engineering scaffolds, 
and drug delivery. Chapter 3 covers the formulation of colloidal gels, rheological analysis 
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of latex ink, and fabrication 3D scaffolds with various architectures. Chapter 4 presents the 
methods of incorporation of proteins into the scaffold and characterization their distribution, 
release behavior and bioactivities. Finally, chapter 5 draws conclusions from the complete 
work and proposes future directions to improved colloidal gel formulation and cell culture 
experiments. 
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Chapter 2 Background 
 
2.1 Polymer Latex 
2.1.1 Definition 
Colloid refers to system in which one or more of the components have at least one 
dimension within the nanometer (10-9m) to micrometer (10-6m) range.[14] As a subclass of 
colloidal materials, polymer latex is an aqueous colloidal suspension of polymer particles, 
that is to say,  the suspension medium is aqueous and the dispersed phase is polymeric in 
nature.[15] 
2.1.2 Particle Interaction 
A characteristic feature of colloidal suspensions is the large surface area-to-volume 
ratio of the particles involved. Interactions between the dispersed particles are evident and 
play a very important part in determining the physical properties of the system as a whole. 
The phenomenological and mathematical descriptions of suspension stability and rheology 
depend on understanding the nature of attraction and repulsion forces between particles. 
There are three major inter-particle forces governing colloidal stability: 1) van der 
Waals forces are a consequence of the spontaneous fluctuation of the electronic clouds of 
atoms in one material causing a corresponding fluctuation in neighboring materials, which 
leads to an attractive force.[16] This long-range force is omnipresent and always attractive 
between like latex particles and is the predominant driving force for particle aggregation in 
the suspension systems;[17] 2)  electrostatic forces are resulted from mutual repulsion of 
particles with a similar surface charge as most latex particles are electrically charged and 
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with same surface chemistry. The repulsive electrostatic potential energy, Velect decreases 
exponentially as the distance between particles increases and the magnitude increases with 
increasing surface charge amount. Additionally, Velect depends on the dielectric properties 
and ionic strength of the intervening medium. In colloids containing opposite charges, Velect 
may become attractive and lead to particle aggregation; 3) steric repulsive forces are 
genetated between the particles when the particle surfaces in colloids are covered with 
nonionic material layers (usually polymeric in nature) in order to control the stability of the 
colloid. When polymer brushes adsorbed on adjacent particles interpenetrate, entropy will 
decrease and this provides a strong thermodynamic barrier to prevent particle aggregation 
known as steric hindrance. If the solubility of the adsorbed brush is altered by solvent 
conditions or a favorable energetic mechanism (e.g. hydrogen bonding) exists, the polymer 
brush can act to aggregate the particles. 
2.1.3 Stability 
A suspension in which the particles remain separated from one another for long periods 
of time is said to be stable. There are at least two ways to reduce the tendency for latex 
particles to aggregate: 1) electrostatic stabilization: the particles can acquire the 
stabilization by electrostatic repulsion between particles, arising from ions that are either 
adsorbed by or dissolved from the surface of the particles; 2) steric stabilization: The 
particles can be sterically stabilized by anchoring a thick layer of nonionic materials, such 
as hydrophilic polymers, as stabilizer which itself can prevent close approaching. In reality, 
the two mechanisms of stabilization often occur together whereas probably one is 
predominant and the other is relatively minor. 
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In the case that the colloid is electrostatically stabilized, the stabilization mechanism 
can be explained by DLVO theory.[18] The determinant of colloidal stability is the balance 
between the van der Waals attraction (VA) and the repulsive potential energy (VR) resulting 
from the existence of the electrical double layer (EDL), which is in turn caused by 
contamination of colloidal particles by electrostatic adsorption of free ions in solution to the 
their surface.[16, 19, 20] The total interaction potential of latex can be expressed in Equation 
2.1. 
                          RAT VVV += = ( ) H
aAHakTn
12
exp64 1212
2
0 −−κκ
γπ  (2.1) 
where VT is the total energy, n0 the concentration of counter-ions at infinite distance, a 
particle radius, k the Boltzmann constant, T the absolute temperature, γ surface potential, 
1/κ the Debye-hukel screening length, and H the separation distance between two particles. 
If a monotonically decreasing energy potential persists up a primary minimum with 
decrease of inter-particle distances, no energy barrier prevents the system from reaching 
this minimum and it easily leads to irreversible association or coagulation. While if there 
exist a maximum energy potential prior to the primary minimum and the maximum is 
sufficiently high, the maximum serves as a barrier to particle coagulation and allows the 
existence of secondary minimum that may lead to reversible association or flocculation. 
The extent to which the association is reversible between particles depends on the depth of 
the potential well and on the possible further processes in the aggregate state. 
Sterically stabilized latexes may use AB block copolymers, in which the A-block is 
hydrophilic and B-block hydrophobic, as stabilizers. This molecule sit at a particle/water 
interface with B-block serving as an anchor and the A-block snaking out into the aqueous 
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medium. Therefore, this mechanism of stabilization clearly depends upon the free energy 
of mixing (∆Gm) between the A-segments of the steric stabilizer and the solvent. If ∆Gm is 
negative, then there will be favorable mixing such that osmotic pressure mechanism will 
aggregate the particles. According to Flory-Krigbaum solution theory[21], θ temperature 
was introduced to specify the conditions under which ∆Gm just goes to zero and beyond 
which the driving force for stabilization disappears and the system will coagulate.[15] The 
∆Gm can be expressed in following equation.  
                                          ∫⎟⎠⎞⎜⎝⎛ −⎟⎟⎠
⎞
⎜⎜⎝
⎛=Δ dv
v
v
kTG ddsm
'
1
1 2
12 ρρχ    (2.2) 
in which νs is the volume of a chain segment, ν1 the volume of a solvent molecule, χ1 the 
Flory-Huggins interaction parameter, and ρd and ρ’d the segment density distribution 
function of the two inter-penetrating polymer chains, respectively. 
2.1.4 Consolidation 
The formation of film or bulk from polymer colloids is the most important practical 
application of latex because of its relevance to the ink and coating industries. Polymer latex 
consolidation is known to occur in three stages as depicted in Figure 2.1. 
Stage I is the water evaporation and particle packing stage. The first significant work on 
latex drying was performed by Vanderhoff et al.[22] They described drying as a three-stage 
process and correlated each of the stages with structural changes occurring with film 
formation. As evaporation of water from latex suspension proceeds, latex particles come 
closer together and arrange into, preferably, closed packed arrays. The extent of ordering in 
latex is a function of drying rate, volume fraction of particles, ionic strength, and etc.  
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Stage II is the particle deformation stage during which particles deform under the 
influence of capillary forces. As soft latex particles dry, they deform from a sphere into a 
rounded polyhedron and finally to a rhombic dodecahedron structure. Latex particles may 
coalesce to varying extent, depending on preparation temperature, storage time, and 
storage temperature.  
Stage III is the coalescence stage during which polymer diffusion across particle 
boundaries, resulting in the formation of a continuous form.[23] To obtain a strong, 
continuous film or solid bulk, it is necessary that the segments of chain polymer molecules 
diffuse from one globule to another, thus forming a strong link.[24] This stage of film 
formation has been found to be dependant on particle size, stabilizer properties, annealing 
conditions, and diffusion rate of polymer molecules. Increasing of molecular weight (MW) 
and incompatibility of the latex polymers will generally lowers the inter-diffusion rate.  
 
Figure 2.1. Three stages of latex consolidation: stage I water evaporation; stage II particle 
deformation; and stage III particle coalescence. 
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2.2 Freeforming of Polymers 
2.2.1 Introduction 
As opposed to traditional fabrication methods, solid freeform fabrication (SFF) 
technologies build a designed structure directly from digital geometrical data without a 
mold. This additive nature offers great promise for producing objects with customized 
shape, complex internal void, and spatial gradient of material compositions. The basic 
operations of the various SFF techniques are similar, all employ the same basic five-step 
procedures[25]: a) create a CAD model of the design; b) convert the CAD model to 
stereolithography (STL) format; c) slice the STL file into thin cross-sectional layers and 
generate tool paths; d) construct the model one layer atop another; e) clean and finish the 
model. 
2.2.2 Major Techniques 
Stereolithography was developed by 3D systems, Inc.[26] In the process as shown in 
Figure 2.2, a He-Cd or Ar-ion laser traces a shape at the surface of a bath of photo-
polymerizable monomers (mixture of acrylates or epoxies with a photo-catalyst system), a 
supporting platform then drops by one layer of thickness and a further layer of monomer is 
swept across the newly formed surface. The process repeats until the part is completed. 
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Figure 2.2. Schematic of the stereolithography process (courtesy of techok.com) 
SLS (selective laser sintering) uses a CO2 or YAG laser to sinter powder based 
materials together layer-by-layer for making a solid model.[27] In the process as illustrated 
in Figure 2.3, a thin layer of build material is spread across a build platform where the laser 
traces a 2D cross-section of the part to sinter the material together. The platform then 
descends a layer thickness and the leveling roller pushes material from the powder 
cartridge across the build platform, where the next cross-section is sintered to the previous. 
This continues until the part is completed.  
 
Figure 2.3. Schematic of selective laser sintering process (courtesy of uni.edu) 
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FDM (fused deposition modeling) is the second most widely used SFF technology 
after stereolithography.[10]  During the process, a plastic filament is unwound from a coil 
and was supplied to an extrusion nozzle (Figure 2.4). The nozzle is heated to melt the 
plastic and deposits a thin bead of extruded plastic to form each layer. The plastic hardens 
immediately after being squirted from the nozzle and bonds to the layer below. The 3D 
objects can then be constructed layer be layer. 
 
Figure 2.4. Schematic of fused deposition modeling process (courtesy of nus.edu.sg) 
3DP (three dimensional printing) was developed at MIT.[12] The process (Figure 2.5) 
starts by spreading a layer of powders at the top of a fabrication chamber by a roller. The 
multi-channel jetting head subsequently deposits a liquid adhesive in a 2D pattern onto the 
layer of the powders which becomes bonded in the areas where the adhesive is deposited. 
Once a layer is completed, the fabrication piston moves down by the thickness of a layer. 
The process is repeated until the entire object is formed within the powder bed. 
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Figure 2.5. Schematic of three dimensional printing process (courtesy of turkcadcam.net) 
3-D Plotting (three dimensional plotting) techniques have many different versions but 
the procedures and equipments are analogous. All of them use a computer-guided robot and 
a dispenser that is movable in three dimensions (Figure 2.6). The plotting material, being 
stored in a cartridge, is plotted directly on a plate or into the liquid plotting medium through 
a syringe mounted on dispenser.[28-30] The material can be solidified either by solvent 
evaporation or ion crosslinking. 
 
 
Figure 2.6.  Schematic of 3-D plotting process (courtesy of reference [28]) 
2.2.3 Comparison 
The advantages and disadvantages of the SFF techniques for polymer fabrication are 
listed in Table 2.1. All these techniques share the characteristics of being able to make 
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object with freeform surface, internal hole, and complex material gradient, which are not 
achievable by standard forming methods. However to be applied in fabrication of bioactive 
scaffolds, one must consider other properties if not the processes. Stereolithography is 
limited to reactive resins, most of which are toxic. Selective laser sintering exposes the 
supply materials to extreme heating, thus will preclude the use of bioactive molecules in 
the build process. 3DP techniques are subject to the difficulty of growth factor 
incorporation, which is important for the subsequent regulation of cellular activity, due to 
the particle preparation process. 
Table 2.1 Capabilities and limitations of various SFF techniques 
 
 
SFF technique 
 
Classification 
 
Materials 
 
Advantage 
 
Disadvantage 
 
Stereolithography Lithography Reactive resins Good mechanical strength 
Limited to reactive 
resins (mostly toxic) 
 
SLS Lithography 
Metals, ceramics, 
bulk polymers, 
compounds 
High accuracy. 
Good mechanic 
Strength. 
Broad range of bulk 
materials 
Elevated temperature-
local high energy input 
Uncontrolled porosity 
 
 
 
FDM Extrusion 
Some 
thermoplastic 
polymers/ceramics
Low cost 
Elevated temperature 
Small range of bulk 
materials. 
Medium accuracy 
 
3DP Lithography 
Ink + powder of 
bulk polymers, 
ceramics 
No inherent toxic 
components, 
Fast processing 
Weak bonding between 
powder particles 
 
3-D plotting Extrusion 
Swollen polymers 
(hydrogels), 
Thermoplastic 
polymers, reactive 
resins, ceramics 
Broad range of 
materials, conditions.
Incorporation of cells 
and proteins 
Slow processing 
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2.3 Tissue Engineering Scaffolds 
2.3.1 Tissue Engineering 
When tissues or organs become diseased or damaged, a physician normally has little 
recourse but to replace them. Harvesting the patient’s tissue from a donor site and 
transplanting it to a host site has become the “gold standard” for many surgical 
procedures.[31] However, this therapy has obvious limitations such as donor site scarcity, 
pathogen transfer, and immune rejection. To address these problems, autogenous tissue 
transplantation and regeneration based on tissue engineering (TE) technique has emerged 
as a very promising alternative treatment.[4] With this approach, a biopsy of stem cells 
obtained from the patient’s own tissue is seeded into a temporary 3-D scaffold, which 
serves as an adhesive substrate and a physical support for implanted cells to proliferate, 
secret their own extracellular matrices (ECM) and finally form the new tissue or organ. 
During the process of cell growth, the scaffold gradually degrades and eventually 
disappears (Figure 2.7).[4]  
 
Figure 2.7. Schematic of the tissue engineering approach. 
2.3.2 Scaffold Design Criteria 
In order to form artificial tissues with right configuration and functions, scaffolds must 
meet certain design criteria[32-36]: 1) biological aspect: the scaffold should have a 
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controllable degradation rate to match the rate of tissue regeneration and cell friendly 
surface physicochemical features to facilitate cell adhesion, spreading, migration, 
proliferation in vitro and cell recruitment and healing at the tissue-scaffold interface in 
vivo.[37, 38]  Neither the scaffold materials nor its degradation products should be toxic or 
provoke inflammation;[1, 39] 2) structural aspect: scaffold should have high porosity and 
pore interconnectivity that allows the unhindered diffusion of nutrients[40] and removal of 
metabolic waste.[41, 42] Scaffold should have high internal surface area to accommodate the 
large numbers of cells and controllable pore size to fit various tissue microenvironment; 3) 
mechanical aspect: scaffolds should have sufficient mechanical strength during in vitro cell 
culturing to manage any in vivo stresses and physiological loadings, especially for 
regenerating load-bearing tissues (e.g., cartilage, bone).[42, 43] The degradation behavior of 
the scaffold should be designed so that it retains sufficient structural integrity until the 
newly grown tissue has replaced the supporting function of the scaffold.[42] 
2.3.3 Scaffold Materials 
The most common biomaterials used for tissue scaffolds fall into two major categories: 
synthetic polymers, and natural polymers. 1) Synthetic polymers have the distinct 
advantages that their mechanical, chemical, and biodegradation properties can be 
engineered by molecular design to fit a particular need.[44] Poly(lactic acid), poly(glycolic 
acid), and their copolymers PLGA are the most widely used synthetic biodegradable 
polymers available[45, 46] because of their controllable degradation rate and highly regulated 
metabolic removal mechanism of their degraded monomeric components.[47, 48] Due to 
these properties, PLGA materials have been used extensively to fabricate scaffolds for 
engineering musculoskeletal tissue, including scaffolds for bone,[49-51] cartilage,[52-55] and 
 
17
meniscus.[56] 2) Natural polymers: naturally occurring polymers such as collagen and 
glycosaminoglycan (GAG) based materials are the most widely used natural polymers in 
tissue engineering[57, 58] The prevalence of collagen in the majority of human tissue 
underlies its ability to support the growth and function of a wide variety of cell types. In 
particular, GAG has been shown to regulate cell functions and play an important role in 
tissue development and repair.[59] However, natural polymers have major limitations, such 
as poor mechanical property control ability and potential immunogenic properties.  
2.3.4 Scaffold Fabrication 
The scaffold fabrication processes are also subject to certain requirements. First, the 
processing conditions should not adversely affect chemical properties and biocompatibility 
of the scaffold nor cause any degradation in its mechanical properties. The processing route 
should lead to spatially and anatomically accurate 3-D scaffolds structures. Also different 
scaffold batches are supposed to exhibit minimal variations in physical forms and 
properties when produced from the same set of processing parameters. In addition, the 
technique should be able to produce scaffolds that fit the intended spaces at the implant site 
with controlled pore morphologies, pore distribution and interconnectivity designed for 
each tissue engineering application. 
Conventional techniques of scaffold fabrication include fiber bonding[60, 61], phase 
separation[62, 63], solvent casting/particulate leaching[35, 64-66], membrane lamination[67], melt 
molding [68], gas foaming/high pressure processing[69, 70], hydrocarbon templating[71], freeze 
drying [72, 73] and combinations of these techniques (e.g., gas foaming and particulate 
leaching[74]). Although these methods have been applied to engineer a variety of tissues 
with varying success, they are limited by numerous drawbacks which restrict their scope of 
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applications, such as extensive use of toxic organic solvents[73], residual porogen,[75] and 
highly inconsistent macro- and micro- structures (pore sizes, pore morphologies, porosities 
and internal surface areas).  
2.4 Controlled Release 
2.4.1 Introduction 
A controlled release system is a combination of active agent and excipient, commonly a 
polymeric material, designed to allow delivery of the agent to the target at a controlled rate 
over a specified period of time.[76, 77] According to the mechanism used to control the drug 
release, the design of controlled release devices is mainly based on one of these categories: 
1) diffusion controlled system, 2) bioerodible controlled system, and 3) swelling controlled 
system.[78-84] 
2.4.2 Diffusion Controlled System 
In terms of diffusion controlled system, polymeric materials are designed either in the 
form of the carrier materials or the permeable membranes to form two basic types of 
diffusion controlled systems[85]: matrix and reservoir devices. A reservoir device (Figure 
2.8(a)) is the simplest diffusion-controlled system consisting of an inert diffusion barrier 
membrane enclosing the active agent to be released. The drug release rate is determined by 
choice of membrane material and partition coefficient of the drug to be released. In a 
matrix device (Figure 2.8(b)), the active agent is uniformly dispersed, either molecularly or 
as solid drug particles, throughout an inert polymeric matrix. The drug release can be 
modified by varying of drug loading, nature of carrier material (polymer) and additives, 
and device geometry.[81] 
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Figure 2.8. Schematic diagram of the diffusion controlled system: (a) matrix system and 
(b) reservoir system 
The release rate in diffusion controlled system is essentially governed by the Fick’s 
diffusion law. The principal advantage of reservoir system is the ease they can be designed 
to achieve zero order release profile, the ideal kinetics from a pharmaceutical standpoint. 
The release rate of membrane controlled reservoir is determined by the following equation: 
)( 12 CC
DKA
dt
dM t −−= δ   (2.3) 
where D is the diffusion coefficient, δ the membrane thickness, Mt the amount of drug 
release at time t, K the partition coefficient, A the surface area, and C2 and C1 are the drug 
concentration inside and outside of the membrane, respectively. To maintain a constant 
flux, the drug can be loaded to a level far above the solubility of the drug to keep the drug 
concentration gradient constant. In matrix systems, the drug release kinetics is calculated as 
in Equation 2.4. for drug loaded spherical particles under perfect sink condition.[86] 
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where M∞ is the amount of drug release at infinite time and Rs denotes the radius of the 
particle. Generally, the release rate is proportional to t1/2 in short time and exhibits 
exponential decay for long time.[87]  
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2.4.3 Bioerodible Controlled System 
In these systems, the drug is distributed throughout a polymer in the same way as in 
matrix systems. The difference, however, relates to the fact that drug release is due to the 
erosion of the polymer phase instead of diffusion. The rationale for using biodegradable or 
bioerodible systems is that the devices are eventually adsorbed by the body or environment 
and do not require removal after administration.[88, 89] The mechanism(s) of polymer 
degradation can be either surface degradation, bulk degradation, or the combination of both 
(Figure 2.9).  
 
Figure 2.9. Schematic diagram of the bioerodible controlled system: (a) surface erosion 
system and (b) bulk erosion system. 
The release kinetics of bioerodible controlled release device depends on the 
biodegradation rate of the polymer and is generally expressed as follows.[82]  
ee
t AK
dt
dM =
 (2.5) 
where Ke is the reaction or dissolution rate, Ae is the instant surface area. For various 
geometries, the solution to this expression is:[82] 
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                      (2.6) 
Thus, to obtain zero order release, it is necessary to utilize a geometry where the surface 
area does not change as a function of time, a slab is such a shape, on the other hand, sphere 
and cylinder would display decreasing rates with time because their surface area would 
diminish.  
2.4.4 Swelling Controlled System 
In swelling controlled systems, the bioactive agent is originally dissolved or dispersed 
within a glassy polymer matrix and there is no drug diffusion. As the environment fluid 
penetrate the matrix, the polymer swells into a rubbery state and it allows the incorporated 
drug to diffuse outward.[90] The dimensionless diffusion Deborah number De defined as the 
ratio of the characteristic stress relaxation time of the polymer swelling agent system, λ to 
the characteristic time for the diffusion of the dissolution medium θ, characterize the region 
of observation of Fickian or non-Fickian (anomalous) diffusion.[91, 92] Fickian diffusion is 
observed for De >> 1 or for De << 1, non-Fickian diffusion behavior occurs when De of 
order one. Drug release from a thin slab, under countercurrent diffusion of a swelling agent 
in a glassy polymer may be expressed by equation. 
nt kt
M
M =
∞
 (2.7) 
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Where k is a empirical factor. Fickian diffusion occurs when n = 0.5, while Non-Fickan 
diffusion is characterized by n > 0.5. 
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Chapter 3 Tissue Engineering Scaffold 
 
3.1 Introduction 
The goal of tissue engineering is to regenerate bodily tissues by seeding cells onto 
three-dimensional (3D) porous matrices, know as scaffolds, which direct the cell growth 
and tissue remodeling.[2, 93, 94] The common practice of seeding cells on two dimensional 
(2D) substrates often leads to distorted metabolism and gene expression pattern and cell 
morphology owing to altered extracellular context.[95] Alternatively, culturing cells in 3D 
scaffolds results in a microenvironment more closely resembling that found in vivo[96] such 
that the seeded cells respond to mechanical and biological cues from the all 3D locations 
that promote cell adhesion, proliferation and differentiation. Suitable tissue scaffolds are 
subject to certain design criteria, e.g. scaffolds should have features such as interconnected 
pore structure, cell friendly surface chemistry and incorporated vital growth factors that are 
released to encourage successful tissue growth.[32-36, 43] 
  During the past decades, a variety of techniques have evolved to build 3D structures 
for tissue scaffolds.[10-13] Conventional techniques of scaffold fabrication, such as salt 
leaching, by using simple porogens have had only limited success in fabricating scaffolds 
with complex microstructures.[97] Solid freeform fabrication (SFF) technologies have 
shown varying success in fabricating scaffolds with designer internal and external 
microstructures, with better control over localized pore morphologies, porosities, and 
material composition to suit the requirements of multiple cell types arranged in hierarchical 
structures.[1, 98, 99] However, most SFF processes require harsh processing conditions like 
 
24
elevated temperature, toxic solvents, or intense local radiation.[100] Such settings would 
denature highly sensitive biomolecules (e.g. growth factors); hence precluding their use to 
modulate cell growth and restricting their scope of applications. The benefits of including 
growth factors, which have been observed in several solvent-free, aqueous processes, have 
been limited to crosslinkable hydrogels, which may be physically weak and lack molecular 
design flexibility.[101] 
Here, an aqueous, low temperature based SFF technique for scaffold fabrication was 
developed. The SFF process consists of formulating colloidal gel with polymer latex 
particles to be used as inks in a 3D direct write process. The colloidal gel has rheological 
properties that allow for it to be extruded as a rod with circular cross section.  The extrusion 
nozzle is moved relative to a substrate to draw two dimensional patterns and 3D structures 
result when the 2D patterns are drawn in successive layers. The ink design allows the use 
of latex particles prepared from mechanically strong but water insoluble synthetic polymers 
as the colloid phase. Unique to selective laser sintering (SLS) or fused deposition modeling 
(FDM) techniques that require the feedstock to be processed at a temperature beyond its 
melting temperature (Tm), the colloidal gel based technique only demand the processing 
temperature comparable to or higher than the glass transition temperature (Tg) of the latex 
polymers, which is far lower than the corresponding Tm. In addition, this process is further 
facilitated by the capillary forces generated in water evaporation that drive particle 
densification to increase structure integrity. Upon drying of the ink, the polymer particles 
consolidate under biologically benign conditions (aqueous, < 37 oC) to evolve mechanical 
strength. Consequently, labile biomolecules, solitarily or microencapsulated, may be 
incorporated in the ink design by co-dispersion with latex particles to be released upon 
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seeding of the scaffold. The aqueous suspensions also contain dual-purpose dissolved 
biopolymers to impart the scaffolds with bioactive chemistry for cell attachment and 
proliferation as well as functioning as processing aids for manipulating the rheological 
properties of the ink. For successful printing in the SFF process, two critical behaviors are 
required of the ink: 1) it must flow readily through a small nozzle; 2) it must set rapidly to 
retain its shape.  
As a model system, non-degradable polyacrylate was chosen in this work for latex 
particles because it has a long history of being applied in biomedical fields.[102, 103] Also 
its resistance to degradation during scaffold fabrication and rheological characterization 
ensures latex compositional and structural stability during the entire deposition and 
rheological characterization. Nevertheless, the process described in this paper can be 
easily transferred to other synthetic biodegradable polymer such as PLGA and PCL, 
which will be discussed later. The inks described here consist of latex particles and 
poly(ethylene oxide)-poly(propylene oxide) (Pluronic) block copolymers in aqueous 
solution. Ink rheological properties were characterized as a function of particle volume 
fraction and binder concentration. In addition, cell culture and cell viability testing were 
performed to check cytotoxicity. 
3.2  Materials and Methods 
3.2.1  Material System 
Acrylic polymer latex (Elotex Titan 8100, National Starch & Chemical, Bridgewater, 
NJ, USA) was generously donated. As described by the manufacture, the latex has a glass 
transition temperature (Tg) of 10 °C and minimum film forming temperature (MFT) of 0 
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°C. The latex is in the form of a granular powder and can be easily redispersed in water 
due to an adsorbed poly(vinyl alcohol) stabilizer.  The average particle size of the latex 
samples is about 0.5 μm. Acrylic polymer was chosen because it has a long history of 
being applied in biomedical fields.[102, 103] Also its resistance to degradation during 
scaffold fabrication and rheological characterization ensures latex compositional and 
structural stability during the entire deposition and rheological characterization. 
Nevertheless, the process described in this paper can be easily transferred to other 
synthetic biodegradable polymer such as PLGA and PCL. Chitosans (Sigma-Aldrich, St 
Louis, MO, USA) of medium viscosity (200-800 cP) and low viscosity (20-200 cP) were 
purified before use by passing the 1% chitosan acetic acid solution through a paper filter, 
precipitating with NaOH solution, washing  twice, and drying in a freeze dryer. The 
viscosity of chitosan solutions was measured in a capillary viscometer and molecular 
weight (MW) of the chitosan was calculated according to method previously 
described.[104] Tripolyphosphate (TPP), bovine serum albumin (BSA) and Pluronic F127 
(cell culture tested) were all purchased from Sigma-Aldrich and used as received. 
3.2.2 Formulation of Colloidal Gels 
Prior to material formulation, the latex particles were dispersed in a large quantity of 
distilled water for purification.  Next, the suspended latex particles were centrifuged 
(20000×g for 30 min), decanted, redispersed in distilled water and treated with 2~5 g 
silica gel (Davidsil grade 923, Sigma-Aldrich, St. Louis, MO, USA). After each treatment, 
the silica gel was separated by use of a stainless steel sieve (pore size 50μm). The 
centrifugation–redispersion-silica treatment cycles were repeated at least five times. 
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Finally, the latex was cleaned by dia-filtration with distilled water using a tangential flow 
filtration (TFF) system (Labscale TFF, Millipore, Billerica, MA, USA) and freeze dried. 
The calculated amount of Pluronic F127 was first dissolved in distilled water at 
temperature of 4 oC.  Next, an appropriate volume fraction (0.47 ~ 0.62) of latex particles 
was added to the solution and a stable suspension was formed. The suspension was 
vigorously homogenized for 5 min using a homogenizer followed by processing with a 
three-roll mill for 5 minutes. The suspension was brought to room temperature and the final 
colloidal gel was formed due to the thermogelling behavior of the Pluronic binder at 
ambient temperature. In this work, the volume fraction of latex particle in the total material 
is designated as φparticle while the volume fraction of Pluronic F127 (assume density = 1.0 
g/ml) in the total material is designated as φPluronic. The volume fraction of Pluronic F127 in 
the liquid phase is designated as φ'Pluronic. 
3.2.3  Rheological Characterization 
The rheological properties of colloidal gels were characterized using a controlled 
stress rheometer (Bohlin C-VOR, Malvern Instruments, Southborough, MA, USA) fitted 
with a C-8 cup-and-bob geometry. The apparent viscosity (ηapp) was measured in stress 
viscometry mode, which has a stress range of 0.01 to 500 Pa with a lower shear rate limit 
of 0.05 s-1. Shear rate ( ) data were acquired as a function of shear stress (τ) in an 
ascending series of discrete steps with a 1 min equilibration time at each stress.  The elastic 
shear modulus (G') was measured in oscillatory mode, which has a stress range of 0.01 to 
500 Pa, a strain sensitivity of about 10-4. G' was measured by performing a stress sweep at 
a frequency of 1 Hz. The stress sweep was repeated several times after observing a 
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quiescent equilibration time of ~1 h between measurements. All measurements are 
performed at 25 ºC using a specially designed solvent trap filled with deionized water to 
minimize evaporation. 
3.2.4  Robotic Deposition of Scaffold 
In this study, a specially designed gantry robotic deposition apparatus (Aerotech Inc, 
Pittsburgh, PA, USA) was used to control the position of the deposition nozzle for 
scaffolds fabrication (Figure 3.1). Three axes of motion control (X, Y, and Z-axis) were 
provided by the gantry system and a material delivery assembly comprised of a syringe as 
reservoir was affixed on the z-axis motion stage. The z-axis motion stage assembly was 
mounted on a moving X-Y gantry to enable controlled motion of the mounted syringe in 
three dimensions. A fourth linear actuator (U-axis) served to depress the plunger of the 
syringe at a fixed speed such that the volumetric flow rate could be precisely controlled. 
The material housed in the syringe was deposited through a cylindrical nozzle (diameter = 
150 µm) such that the extruded filament is bent immediately after exiting the nozzle to lie 
parallel to the x-y plane. Toolpath design and motion control were accomplished with 
custom software designed by the investigators.  
   Polymer scaffolds were fabricated by directly dispensing the colloidal gel material 
onto a polypropylene plastic film using the robotic deposition device. The 3D meshes were 
assembled by depositing arrays of lines one atop another.  The cuboid scaffolds with 
tetragonal symmetry were assembled by stacking layers with alternating aligned linear rods 
along x or y-axis such that their orientation was orthogonal to the previous layer.  The rod 
spacing for the layers was varied from 300 to 1200 μm and the rod diameter was held 
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constant at 150 μm.  The resulting theoretical volume fractions of rods in the scaffold 
varied from 0.58 to 0.86. The cylindrical scaffolds with radial symmetry were constructed 
with sequential deposition of layers having alternating patterns of concentric rings and a 
polar array of radially oriented rods. 150 μm nozzles and deposition speed of 5 mm/s were 
used in the assembly of these structures. The layer spacing was fixed at 95% of the nozzle 
diameter. 
 
Figure 3.1.  3-D drawings of (a) the robotic deposition apparatus 
and (b) the syringe holder on the fourth actuator. 
Immediately after deposition, the wet scaffolds were dried in an incubator at a 
constant temperature of 37 oC for at least 1 hour.  The drying behavior was observed by 
weighing the scaffold at various times during the drying. To arrest the further particle 
deformation and coalescence, the dried scaffolds were stored in a – 30 oC freezer.  The 
dried scaffolds were cut with an ultra-short pulse laser through the intersections between 
rods to reveal the internal structure. The scaffolds were observed under the scanning 
electron microscope (SEM) to assess the morphology. 
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3.2.5  Cell Culture 
Green fluorescent protein (GFP) transfected quail mesodermal cells (QCE6) were 
generously provided by Dr. Carol A. Eisenberg (Medical University of South Carolina, 
Charleston, SC) [105]. The inherent GFP fluorescence of the cells was utilized as an indicator 
of cell viability (fluorescent = living, non-fluorescent = dead). In this study, the QCE6 cells 
were seeded onto the fabricated scaffolds and kept in culture for 14 days to determine 
cytotoxicity of the scaffold material on cultured cells. First QCE6 cells were detached from 
the flask by applying 0.25% Trypsin/EDTA and counted with a hemocytometer. The cell 
suspensions were centrifuged and cell pellets were re-suspended in the media to a cell 
density of 1 million per ml. Cuboid scaffolds (L¯W¯H = 1.2 mm¯ 1.2mm ¯0.9mm, rod 
diameter = 150 μm, rod spacing= 300 μm) were immersed in 70% ethanol for 5 min, 
subsequently washed three times with water and then coated with 1% alginate prior cell 
seeding. Aliquots of 30 μl cell suspensions were pumped into the scaffolds with a syringe 
pump (Harvard apparatus, Holliston, MA, USA) at a rate of approximately 3 ml/hour in the 
complete SAGM media. The cells were kept at 37 oC by a microscope stage warmer, and 
seeding of the scaffold was monitored by intermittent epi-fluorescent microscopy. Cultures 
were maintained at 37oC with 5% CO2 in a humidified chamber for a two week period. At 
the termination of the experiment, the formed tissue constructs were examined by a 
confocal laser scanning microscope (CLSM, Leica SP2, Bannockburn, IL) set to detect 
GFP. The fluorescence image of tissue construct was obtained by optically scanning in the 
x-y planes (parallel to the substrate) with 26 scan averaging from top of the scaffold. The 
total z scanning depth is 250 μm and each slice is 10 μm in thickness.  
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3.3  Results and Discussion 
3.3.1  Rheology of Colloidal Gels 
The apparent viscosity (ηapp) as a function of shear rate ( ) for concentrated latex 
gels (φparticle = 0.57) containing various amount of Pluronic F127 is plotted in Figure 3.2(a) 
and the elastic modulii (G') of the colloidal gels are plotted as a function of stress amplitude 
(τ) in Figure 3.2(b). When the Pluronic volume fraction† (φPluronic) was 0.05, the latex 
suspensions displayed only weak shear thinning and a negligible yield stress as shown in 
Figure 2.2(a). With the increase of Pluronic addition from 0.05 to 0.06, ηapp of the latex 
suspension was boosted almost 10 fold at low shear rate and its rheological behavior 
became significantly shear thinning. Beyond this Pluronic concentration, the colloidal gels 
strengthened and exhibited pseudoplastic behavior with a yield stress. This shear thinning 
with yield stress rheology can be described by the Hershel-Bulkley model given by 
                                                 ny Kγττ &+=  (3.1) 
where τy is the yield stress, n is the power law index, and K is the consistency index. In 
Figure 2.2(b), G' displayed a well-defined plateau (G'eq) in the linear viscoelastic region as 
the stress amplitude was increased. When the stress amplitude reached the yield stress, G' 
rapidly decreased. The yield stress was considered to occur when G' = 0.9G'eq. [106]  As 
illustrated in Figure 2.2, the addition of increasing amounts of Pluronic polymer results in a 
gradual increase in both the ηapp and G' for the gelled latex suspension. Interestingly, ηapp 
of the latex gels reach a maximum at about φPluronic = 0.08 and begin to decrease with 
                                                 
† φPluronic is the with respect to the total volume of the suspension, the volume fraction in the liquid phase is φ'Pluronics = φPluronic (1- 
φparticle)-1 
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further increase of φPluronic.  This behavior suggests that the Pluronic is adsorbed to the latex 
particle surface and forming a hydrogen bonded gel network, however at high 
concentration of Pluronic, particle poor regions of gel may exist that weaken the overall 
structure.  
                
 
Figure 3.2.  Rheological behavior of latex gels with fixed φparticle = 0.57 illustrating (a) 
apparent viscosity (ηapp) and (b) shear modulus (G') as a function of varying φPluronic  and 
shear rate ( ) or shear stress amplitude (τ), respectively. The inset demonstrates the fit of 
the Hershel-Bulkley model for shear stress (τ) as a function of .  
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Figure 3.3.  Rheological behavior of latex gels with φPluronic = 0.08 illustrating (a) 
apparent viscosity (ηapp) and (b) shear modulus (G') as a function of varying φparticle  and 
shear rate ( ) or shear stress amplitude (τ), respectively.  The inset demonstrates the fit of 
the Hershel-Bulkley model for shear stress (τ) as a function of . 
The effect of latex particle volume fraction (φparticle) on suspension rheology and 
viscoelastic properties are shown in Figure 3.3(a) and Figure 3.3(b), respectively. For each 
suspension, φPluronic = 0.08 (φ'Pluronic = 0.151~ 0.211). At this Pluronic concentration, all 
latex suspensions measured exhibited shear-thinning with yield stress rheology, suggesting 
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the validity of the Hershel-Bulkley model within the φparticle range.  As expected, ηapp and 
G' increase with increasing of φparticle for the colloidal gels.  At φparticle = 0.50, the yield 
stress of the colloidal gel is 13.8 Pa and increases more than 10 fold to 164 Pa when φparticle 
= 0.55.  With φparticle = 0.62, the system approaches the maximum solids loading and 
processing become extremely difficult.  
With the initial addition of Pluronic into acrylic latex suspension, the tri-block 
copolymer is expected to adsorb such that the hydrophobic PPO section in the middle 
anchors on the particle surface whereas the solvated PEO blocks extend out into the 
solution as tails and loops[107] as shown in Figure 3.4.  Pluronic forms a hydrogel at room 
temperature when the concentration in solution exceeds ~20%.  The gels shown here 
have a maximum concentration of Pluronic in the liquid phase of 23%, but significant 
gelation below this concentration suggests that PEO strands extending from neighboring 
particles can participate in a gel network at lower concentrations.[108]  The particles act to 
further strengthen the colloidal gel structure. Beyond the minimum gel point, additional 
linkages form between particle cluster with the further addition of Pluronic resulting in the 
observed increase of ηapp and G’. This gelation behavior can also be expected to happen as 
the particle volume fraction increase over a threshold value as it has the similar effect to 
encourage the entanglement and association of Pluronic chains.  
The colloidal gels initiated by physical association of the Pluronic coated particles are 
not strong enough to keep the network intact when subject to high shear conditions such as 
deposition. In this case, the colloidal particulate network becomes temporarily disrupted to 
exhibit a shear thinning rheology. [109-113]  Upon returning to a quiescent state, the network 
is re-established rapidly and the material returns to the gel state.[106, 114] The ability to break 
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down and re-build their structure makes gel-based materials well suited to fulfill the 
requirements of flow through a deposition nozzle with low viscosity and to rapidly “set” to 
maintain the shape of the deposited filament even as it spans gaps in the underlying layers.  
Thus colloidal gels possess viscoelastic behavior that makes them ideally suited for 
assembling such structures. [106, 109-112, 115-122]  
   
Figure 3.4. (a) Schematic of the conjectural configuration of suspended latex particles 
with Pluronic polymer chains adsorbed on the surface with middle PPO section anchors 
on the particle surface whereas the PEO blocks extend out into the solution. (b) 
Schematic of the reversible particle networks existed in the colloidal gel. The colloidal 
gel has a unique feature that it can undergo a reversible transformation between the 
discrete particle suspension when under high shear (left column) and percolating network 
structure once return in quiescent state (right column)  
3.3.2 Scaffold Fabrication 
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Scaffolds with periodic lattice structure of tetragonal and cylindrical symmetry, shown 
in Figure 3.5, were assembled from colloidal gel based materials. The cuboid scaffold in 
Figure 3.5(a) is a lattice of rods stacked with simple tetragonal symmetry, where the rod 
spacing within each layer resulted in a planar filling fraction of 0.50.  As can be seen in 
Figure 3.5(b) and (c), the scaffold rods maintained a circular cross section and spanned the 
gaps in underlying layers with minimal deflection. The cylindrical scaffolds in Figure 
3.5(d), (e), and (f) have a radial symmetry built by stacking layers of arrays of radial lines 
between layers of concentric rings.  The pore size and volume fraction in these structures 
decreases from the outer to inner radius.  
The diverse nature of tissue architectures requires controlled variation of the  
microenvironment for cell proliferation and differentiation.  Favorable pore sizes and pore 
structure along with strut size between pores are critical factors.  The nominal feature size 
of the extruded material filament is in the range of 100~200 µm but 50 µm has been 
successfully accomplished.  Filaments in this size range are regarded as near optimal for 
culturing a variety of mammalian cells.[12, 123]  With a fixed deposition nozzle size, the 
robotic deposition process used here may assemble scaffolds with variation in pore sizes 
and volume fraction porosity as shown in Figure 2.6.  A larger spacing between adjacent 
lines within a layer result in an increased pore size and volume fraction. Scaffold (1) 
contains the smallest lattice spacing and has a pore volume fraction of 0.23. The lattice 
spacing was increased such that the porosity becomes 0.86 in sample (10). 
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Figure 3.5.  Scaffolds formed by deposition of colloidal gel material.  (a) cuboid scaffold 
with a simple tetragonal symmetry; (b,c) internal structure of cuboid lattices reveal the 
high integrity interfaces formed between layers and circular cross section of lattice rods; 
(d,e,f) cylindrical symmetry scaffolds. Scale bars (a,b,d,e) 1 mm (c, f) 100 μm 
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Figure 3.6.  Microscopic images of stiffened scaffold with varying rod spacing, resulting 
in various porosity ranging from 0.23 to 0.86. All the rods in the scaffolds have the same 
diameter of 150 μm. 
3.3.3  Cell Culture 
To assess the suitability of the polyacrylate produced here for tissue engineering 
applications, GFP transfected quail mesodermal stem cell line QCE6 was seeded into the 
tissue scaffold. Within 5 hours of seeding, the cells began to attach onto the scaffold 
surface and express their own extracellular matrix. During the first week, cells were seen to 
actively grow along the rod and bridge across the pore structure. The cell clusters were seen 
to occupy the interconnected pore space of the scaffolds. By day 10, cells were seen 
throughout the entire scaffold in three dimensions. Before the termination of the culture, 
most of the cells appeared healthy and kept the 3D spherical phenotype.  
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Figure 3.7.  GFP transfected Quail mesenchymal QEC6 cells cultured on tissue scaffold. 
(a) GFP positive cell aggregates are readily observed within the openings of the lattice 
network. (b) CSLM image illustrating expression level of QEC6 cells.  White arrows 
indicate scaffold rods.   
   To assess the cytotoxicity of the scaffold materials, GFP expression of the QCE6 
cell in scaffold was evaluated by analyzing the fluorescence images acquired by confocal 
laser scanning microscopy as illustrated in Figure 2.7.  Although the mean fluorescence 
intensity decreased over time, the GFP expression was still significant after 10 days in 
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culture.  The result demonstrates the ability to culture GFP positive cells on the scaffold 
material while maintaining viability of the cells over the 14-day period, suggesting minimal 
cytotoxicity of the scaffold material to quail stem cell line. Previous experiment on cell 
culture by encapsulating HepG2 cells with Pluronic F127 resulted an unsuccessful result. 
No cell growth was found in the Pluronic gels and most of the cells have died after 6 days. 
This failure was likely due to poor oxygen and nutrient diffusion within the gels.[124]   
3.3.4 Implication of the Material Design 
The utilization of polymer colloidal gels for robotic deposition of scaffolds imposes 
no intrinsic limits on particle properties, provided a gel with the desired rheological 
properties may be formulated.  The deposition feature size, however, is primarily 
dependent on latex particle size. From previous experimental observation, the requirements 
of the nozzle diameter to particle size ratio (D/a) > 300 based on the average particle size 
or D/a > 40 based on the largest particles are normally applied.[125] Therefore, nanometer 
sized colloidal particles may be used to achieve higher D/a and, hence, smaller feature 
size.[126]  
The mechanical strength of the deposited scaffolds evolves in a three step process.  
First, upon exiting the deposition nozzle, the colloidal gel has enough strength to maintain 
its shape, but cannot be easily handled. Second, as water evaporation progresses, the 
capillary forces developed at latex surface drives particle compression and densification, 
resulting in a stronger scaffold. However, the scaffold at this stage will easily be 
disintegrated in culture medium as no strong linking among waterborne polymer particles 
is established. Thus, the autohesion or inter-particle polymer chain diffusion is necessary to 
be developed in the final coalescence step.[24] As latex coalescence ensues, the strength of 
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the scaffold becomes correlated to the extent of coalescence, which is, in turn, largely 
controlled by the difference between the process temperature (Tp) and the glass transition 
temperature (Tg) of the polymer particles. If Tp << Tg, the polymer chain diffusion from one 
particle to another will be difficult to advance and mechanical prosperities of the scaffold 
can not be developed; at the other extreme Tp >> Tg, the healing of particle boundary is fast 
and a coherent and continuous solid will readily form. Thus, to obtain desirable mechanical 
properties in colloidal gel based techniques, Tp should be comparable to or higher than the 
Tg of the latex polymer particles in the colloidal gel. 
Due to the sensitivity of the protein-based growth factors or other bioactive molecules, 
the process temperature cannot exceed 37 oC either in the short or long term. For many 
biodegradable polymers with a low Tg, such as poly(ε-caprolactone) (PCL, Tg = −66˚C),  
polyhydroxyalkanoate (PHA, Tg = 4˚C), polypropylene Fumarate (PPF, Tg = −10˚C), the 
corresponding colloidal particles can be used directly in this process. According to PLA, 
PGA, and their copolymer PLGA, whose Tg range from 35 oC to 65 oC,[127] adjustment of 
their Tg by adding plasticizers or copolymerizing with low Tg  polymers may be used. For 
example, the Tg of the PLGA (85:15) colloidal particles decreases sharply  from 48 oC to 27 
oC by adding 10 % PEG 1500.[128] Consequently, the formulated PLGA colloidal gels can 
then be processed into scaffold and aged to develop a high mechanical integrity. 
The polymer binder is critical for the colloidal gel formation and, preferably, two 
mechanisms can be utilized to induce the colloid-gel transition in a colloidal suspension. 
One is to collapse the extended binder (i.e. stabilizer) layers adsorbed on particle surface to 
induce flocculation and the other is to form the inter-particle bridging by cross-linking 
adsorbed binder on particle surface. Thus the binder should have the ability to transform 
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conformation either under the change of environmental factors (solvent pH or temperature) 
or cross-link by themselves or with other substances. It should be cognizant that the 
crosslinking must be reversible so that the particle network in the colloidal gel can be 
broken under high shear and re-establish after removal of the shear. Therefore, crosslinking 
of the polymer binder should be formed through non-covalent bonding physical forces, 
such as ion bonding, van der waals forces, hydrophobic bonding, and so on. The examples 
of these gelling polymers include thermoresponsive polymers (agar, agarose, kappa 
carragreenan and pluronic), pH dependent polymers (polyacrylic acid), and ionic 
interaction pairs (alginate + calcium ion, alginate + chitosan, polyacrylic acid + 
Polyethyleneimine). Other important requirements for the polymer binder include that they 
should be biocompatible, non-toxic, and biodegradable in some circumstances. 
3.4 Conclusions  
The use of colloidal materials to print 3D scaffolds offers several new directions for 
tissue engineering.  First, solid freeform fabrication of combined synthetic and natural 
polymers is achievable in the same scaffold due to the modular material design.  Second, 
because of the aqueous and low temperature nature of the process, bioactive molecules may 
be readily incorporated into the material for subsequent drug release and biological 
signaling. Third, the scaffolds fabricated can be used directly without extensive and 
laborious purification post-printing steps.  These features may make scaffolds derived from 
printing of colloidal gel materials attractive as tissue engineering scaffolds for a variety of 
applications where pore size control and drug delivery capabilities are desired.  The 
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printing process also enables the possibility of functionally graded structures where drug 
concentrations may be heterogeneously distributed throughout the scaffold. 
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Chapter 4 Controlled Release System 
4.1 Introduction 
The tissue development and functions are vitally dependent on encouragement of the 
cells to proliferate, differentiate, migrate, and interact with each other. All these critical cell 
behaviors are largely regulated through the interplay of a variety of protein based message 
molecules, including large families of growth factors and cytokines.[1, 129, 130] To facilitate 
the therapeutic effectiveness of the regenerated tissues, there is an increasing awareness of 
the need to delivery these signaling factors that mimic their endogenous production profiles 
to the target cell population. However, once administered, the circulatory half-lives of these 
growth factors are short compared to the time required for cell response.[131, 132] Hence, 
incorporation of labile proteins in bioscaffolds and controlled delivery has been extensively 
adopted in tissue engineering.[133, 134] In addition to the demand for the temporal availability 
of the biological factors, the ability to create concentration gradients of growth factors in 
three dimensions is even more important to optimize and speed organogenesis. To date, 
current therapies to regenerate a variety of tissues are restricted to the bolus delivery of 
single growth factor in the entire tissue culture environment, which may not be the ideal 
approach to drive the growth of functionally heterogeneous cells toward highly spatially 
organized arrangement for tissues regeneration. 
The applications of aqueous polymer latex dispersions in pharmaceutical controlled 
release formulations have rapidly increased during the past few years.[135, 136] The 
mechanism for the controlled release relies on the formation of diffusion retardant 
membrane or matrix from aqueous latex such that the drug will be released from a reservoir. 
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However, protein agents present a challenge for aqueous latex dispersion based controlled 
release system as proteins were considered too large to slowly release from the non-
erodible hydrophobic polymers by Fickian diffusion mechanism.[81] On the other hand, 
protein controlled release technology based on hydrogels, three-dimensional hydrophilic 
polymeric networks capable of imbibing large quantities of water, has generated a lot of 
interest.[131] These systems offer a ‘protein-friendly’ environment for the delivery of 
biologically active molecules and the protein release rate can be controlled by of many 
mechanisms, such as dissolution for physically entangled hydrogel and hydrolysis or 
degradation for chemically crosslinked system.[137] Nevertheless, the hydrogels are 
normally weak in physical strength, which limited their application in tissue engineering. 
As demonstrated in last chapter, we have developed a novel direct write technique to 
fabricate tissue engineering scaffolds based on polymer colloidal gels, which is a class of 
materials consisting of a percolating network of attractive latex particles.[138] We 
hypothesize that the distinctive structure of the colloidal gels will allow them to form 
protein release vehicles with both hydrogel-like protein friendly environment and suitable 
mechanical integrity of the latex systems. Beside, the unique viscoelastic behaviors of the 
colloidal gels will make them ideally suitable for assembling arbitrary three-dimensional 
(3D) components capable of spatially controlled growth factor delivery.[106, 109-112, 115-122] In 
this study, strategies were developed to incorporate the proteins in the scaffold to realize 
the localized and sustained delivery. First, we incorporated model protein, bovine serum 
albumin (BSA), into the acrylic based colloidal gels and fabricate them into porous 
scaffolds. To further extend the duration of protein release, we also created composite 
colloidal gels for scaffold fabrication by dispersing BSA encapsulated chitosan 
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nanoparticles in bare colloidal gels. Platelet-derived growth factor (PDGF) was selected as 
a model growth factor and its bioactivity was assayed after release from the scaffolds to 
investigate the protein stability after incorporation. Based on this platform, we also 
explored the possibility to create a functional equivalent of lymphoid tissue by generating a 
heterogeneous scaffold capable of incorporating multiple chemo-attractant (or cytokines) 
and subsequently release to localize lymphocytes and dendritic cells within the artificial 
tissue and finally elicit a desirable immune response. 
4.2 Materials, Methods and Modeling 
4.2.1  Material System 
Bovine serum albumin (BSA) and tripolyphosphate (TPP) were purchased form 
Sigma-Aldrich and used as received. Chitosans (Sigma-Aldrich) of medium viscosity (200-
800 cP) were purified by filtration its solution on glass fiber to remove the insoluble 
substance and de-polymerized to fragments with various molecular weight through sodium 
nitrite degradation.[139] Lyophilized rat recombinant PDGF-BB (R&D system, Minneapolis, 
MN, USA) was reconstituted in HCl solution (0.5 mM, pH = 4.3) with 0.1 wt% BSA to a 
concentration of 0.2 mg/ml. 
4.2.2 Protein Incorporation 
The strategy here to make protein incorporated colloidal gel is to first formulate the 
bare colloidal gel as the base material and then disperse the proteins through mixing, either 
in their original forms or nanoparticle embedded forms. To prepare protein incorporated 
colloidal gels, the calculated amount of model proteins or protein encapsulated 
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nanoparticles were added to bare colloidal gels (prepared according to the protocol 
described in Chapter 3) and mixed for 10 min at room temperature using a home-built 
syringe mixer.[140] In all the cases, the protein loadings are kept with 0.5 wt%. 
BSA encapsulated chitosan nanoparticles were prepared according to the protocol 
reported before.[104, 141] Briefly, chitosan of various molecular weights along with BSA 
were dissolved in 1 wt% acetic aqueous solution at concentration of 1 mg/ml and 0.5 
mg/ml, respectively. Then 2 ml of 1.0 mg/ml TPP solution was added to 5 ml of the 
chitosan-BSA solution. Nanoparticles were formed spontaneously under magnetic stirring 
at room temperature due to ionotropic gelation between chitosan and TPP. The suspension 
was kept magnetic stirring for 30 min and the nanoparticles were collected by 
ultracentrifugation at 20000¯g.  
4.2.3 Scaffold Fabrication 
The scaffolds were robotically assembled by extruding the protein loaded colloidal 
gels as described in Chapter 3. All scaffolds were fabricated in cuboid shape with a 
measuring of 2 mm¯ 1.2 mm ¯0.9 mm. 150 μm nozzles and a deposition speed of 5 
mm/s are used in the assembly of these structures. In all the cases, the rod spacing in each 
layer was fixed at 300 μm and the layer spacing was kept with Δz = 0.95D.  
Immediately after deposition, the scaffolds derived from colloidal gels were dried and 
hardened in a dry incubator at a constant temperature of 37 oC for at least 1 hour. The 
scaffold drying kinetics was obtained by weighing the scaffold at various time points. To 
arrest the further particle deformation and coalescence, the processed scaffolds were stored 
in a –30 oC freezer. Stiffened scaffolds were freeze fractured in liquid nitrogen and 
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observed under the scanning electron microscope (SEM) to assess the internal structure and 
the gross morphology. 
To investigate the protein distribution after incorporation, Texas Red fluorescent dye 
conjugated BSA was mixed with colloidal gels (1 wt%) and fabricated into scaffolds. The 
samples were first frozen in a - 30 oC freezer overnight. Then the scaffolds were embedded 
in a tissue-tek compound (OCT 4583, Sakura, Torrance, CA, USA) and spray frozen with 
coolant (Frostbite, SurgiPath Medical Industry, Richmond, IL, USA). To reveal the radial 
distribution of BSA, 10 μm thick cryostats were cut parallel to layer stacking direction in 
serial sections by a Cryo-Microtome (Jung FrigoCut 2000N, Leica Microsystems, 
Bannockburn, IL) and transferred to microscope slides. The slides were air-dried and then 
examined by an optical microscopy in fluorescence mode. 
4.2.4  in vitro Protein Release 
To characterize the release of a model protein, BSA loaded colloidal gel and colloidal 
gel-nanoparticles scaffolds were incubated in 5 ml 1¯ PBS solution at 37 oC and kept 
shaking at 100 rpm. The supernatants were fully recovered and same amount of fresh 
medium was added at each predetermined time intervals up to 7 days. The resulting 
samples were then analyzed for total protein content by a MicroBCA protein assay kit 
(Pierce, Rockford, IL, USA) and the amount of BSA released per scaffold was calculated 
using a standard curve. 
To validate the bioactivity of released model growth factor, PDGF-BB incorporated 
scaffolds were fabricated with the identical protocol as for model proteins, except the 
PDGF-BB loading was controlled at about 200 μg per scaffold. To quantify actual growth 
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factor release, PDGF-BB scaffolds were precisely weighed and incubated in 1 ml 
Dulbecco's modified eagle's medium (DMEM) at 37 oC. The supernatants were fully 
recovered and same amount of fresh medium was added at each time point up to 14 days. 
Enzyme-linked immunosorbent assay (ELISA) to detect PDGF-BB release was performed 
using a standard rat PDGF-BB kit (R&D system, Minneapolis, MN, USA) and the amount 
of PDGF-BB released per scaffold was calculated using a standard curve. 
4.2.5  Bioactivity Evaluation 
PDGF-BB has been demonstrated as a chemoattractant on fibroblasts[142-144] and this 
chemotactic effect was used to evaluate the bioactivity for released samples from scaffolds. 
The cell migration assay for quantitation of the bioactivities of released growth factors was 
performed in ChemoTX plates (Neuro Probe, Gaithersburg, MD, USA) as described 
previously.[145] In brief, Swiss mouse embryo fibroblasts (NIH 3T3, ATCC) cells were 
labeled with fluorescence markers by rinsing twice with hanks balanced salt solution and 
then incubating in tissue culture flaks for 20 min with carboxy-fluoroscein succinimidyl 
ester (CFSE,10 μM).[146] This medium was then discarded and cells were washed once with 
DMEM with 10% fetal calf serum (FCS), once with DMEM alone and finally incubated 
overnight in DMEM alone. The following day, the serum-starved cells were trypsinized 
and re-suspended in serum-free medium (DMEM medium containing 5 wt% BSA) at a 
concentration of 1×106 cells/ml. The ChemoTX plate with pore size of 5 μm was chosen 
and the experiment was conducted according to manufacturer's instructions. The medium 
containing released PDGF-BB was carefully transferred in the microplate wells. The fresh 
prepared PDGF-BB solution as positive controls and medium with blank scaffold soaked as 
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negative control were also added. Equal amounts of cell suspension (30μl) were loaded 
onto the filters at each site and the migration plate was incubated at 37 oC in a humidified 
atmosphere containing 5% CO2 for 4 h. Migration of cells through the insert membrane 
was assessed by measurement of cellular CFSE fluorescence using a fluorescence plate 
reader with excitation and emission wavelength of 485 and 530nm, respectively.  
4.2.6  Theoretical Modeling 
First we assume that the contact points between layers can be omitted, so the scaffold 
can be regarded as a long folded rod (rod length >> rod diameter) and further approximated 
as an infinite cylinder. Thus the release from scaffold can then be considered as one-
dimensional radial diffusion case in macroscopic scale, as illustrated in Figure 4.1. As the 
latex particles comprising the matrix of the polymer rod are impermeable to the protein, the 
protein transport occurs exclusively within aqueous Pluronic hydrogel filled pores. Also we 
assumed that the porosity kept unchanged during the whole delivery course. 
 
Figure 4.1. The drug release from scaffold can be considered as release from infinite 
cylinder. (a) 3D drawing of the scaffold; and (b) schematic of diffusion from infinite 
cylinder. 
For the infinite cylinder subjected to a sink condition at r = 0, R, the mathematical 
formulation may be written as:  
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where Cp(t,r) is the concentration of protein within Pluronic hydrogel filled pores at r and 
time t, De effective diffusion coefficient, r the radius of the cylinder, R the radius of 
scaffold rod, ε the porosity in the rod, and M the mass of protein originally incorporated 
into the inner rod pores and. The equation was solved in Maple and the solution is:  
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The cumulative drug release at time t may be computed by 
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In addition, we should assume homogeneity of the inner pore distributed in the rod, thus 
constant ε. So the term De may be expressed by  
                                                        pre FDKD =                                              (4.7) 
where Dp is the diffusion coefficient of the protein in Pluronic hydrogel, F is the formation 
factor, which summarize the effect of pore geometry and topology on diffusion, and Kr is 
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the restriction factor, which accounts for the drug/wall interactions induced by 
hydrodynamic and/or electrostatic effects.  In some cases, we can define F as 
                                                           
2
1
τ=F                                                                  (4.8) 
where τ is the tortuosity of the rod pore network, normally ranging 1.5~1.7 in aggregated 
colloidal particles.  
To extend the duration of protein release, proteins were encapsulated in chitosan 
nanoparticles. The protein release from the chitosan particle carrier is mainly due to the 
disassociation of the crosslinked chitosan molecules and de-adsorption of proteins.[147, 148] 
Thus, by addition of a dissolution term, Equation 3.1 becomes:  
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and the dissolution term can be expressed as  
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where k is the chitosan disassociation rate constant, Cs is the protein solubility in chitosan 
nanoparticles, and φcs is the weight percentage of the chitosan particle in colloidal gels. As 
the diffusion in hydrogel is far more rapid than the dissolution process of the chitosan 
particles, so we can neglect the diffusion term and regard system as the sole dissolution 
controlled process. Thus the percentage of the protein release with respect of time can be 
expressed as: 
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where K is the combined constant derived from k, Cs, and φcs. The results indicate that, 
theoretically, the colloidal gel-chitosan nanoparticles composite system has a zero order 
release behavior.  
4.3 Results and Discussion 
4.3.1 Protein Incorporation  
Since the rod of the scaffold was assembled from latex particles and particle 
coalescence toward a continuous solid was arrested after drying, we presume that the 
porosity within the rods still exists. This speculation is partially confirmed by the 
morphological observation of the scaffold samples with extended stiffening treatment 
procedure (dried at 37 oC after 6 hours), as shown in Figure 4.2(a). The rod surface was 
found of granular look at high magnificence, suggesting that the polymer particles in the 
rod were still not fully deformed and interpenetrated with each other. As illustrated in 
Figure 4.2(b), this unique structure can be regard as a sintered particle network with 
Pluronic and protein distributed in the interstitial spaces. Thus, we conclude that the 
scaffold derived from colloidal gels has two levels of pore structure. The primary structure 
is the macroporosity encompassed by the lattice rod arrays while secondary structure refers 
to the microporosity in the scaffold rod, which is formed by the interstices of aggregated or 
sintered colloidal particle networks. The unique secondary structure presents us an 
interesting potential for the incorporation of proteins in scaffold where protein can be 
loaded by dispersing in the interstitial space of the latex particle network. Upon contact 
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with release medium, the water or medium will quickly fill the cavities inside the scaffold 
rod and swell the Pluronic polymers absorbed on the particles to form hydrogels. The 
interstices in the polymer rod matrix become filled with aqueous Pluronic hydrogel, which 
is both the carrier and transport medium for the proteins to get out of the scaffold via 
diffusion. Thus the scaffolds can be utilized as controlled delivery vehicles for proteins, as 
illustrated in Figure 4.2(c). 
To reveal the protein distribution within the scaffold, Texas red labeled BSA was 
incorporated in a scaffold and a 5 micron thin section of scaffold was cut in the radial 
direction of the scaffold rod. Figure 4.3 shows the images of thin section of polymer 
scaffold rods by using light microscopy in bright field and fluorescence mode, and confocal 
microscopy. As opposed to non-uniform surface to the substrate distribution of additive in 
sintered polymeric colloidal films,[149] the BSA is, in general, uniformly distributed 
throughout the diameter in scaffold rod except few air bubbles entrapped inside. The BSA 
locally aggregation and radius compositional difference was not observed even underwent 
with drying and stiffen procures. This phenomenon can be attributed to the trivial mobility 
resulted from large molecular weight of the protein. 
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Figure 4.2.  The colloidal gel based scaffold can be viewed as packed colloidal particles 
with particle sintering. (a) SEM photos of the surface morphology of the scaffold dried at 
37oC after 6 hours; (b) schematic of packed colloidal particles; (c) schematic of two 
levels of scaffold structure and rationale of protein release from scaffold rod. 
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Figure 4.3.  5 micron thin section of the scaffold rod incorporated with Texas red tagged 
BSA protein imaged by light microscopy in (a) bright field mode and (b) fluorescence 
mode, showing the protein dispersed within the microporous structure of the scaffold rod. 
(c) Confocal microscopic image of scaffold rod cross section at a high magnification. The 
scale bars are 100 μm for (a, b). 
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4.3.2  Protein Release 
BSA release behavior from colloidal gel derived scaffolds exhibited a strong 
dependence on post processing conditions. The effect of drying time on protein release was 
shown in Figure 4.4(a). The scaffold dried with 1 to 3 hours release nearly 60% of the total 
protein in 2 hours. After drying more than 3 hours, the protein release rate decreased 
notably and the scaffold dried with 6 hours released 60% of protein in 6 hours. The scaffold 
dried with 20 hours has the similar BSA release profile with scaffold dried with 6 hours, 
indicating that the further increase of drying time has no significant additional retardation 
effect on protein release. As evaporation of water from freshly deposited scaffold proceeds, 
the particles come closer together and a complex sequence of particle consolidation 
occurred due to latex deformation and particle inter-penetration.[22, 150, 151] The particle 
packing and scaffold densification cause not only the decreasing porosity but also the 
increasing tortuosity of the inner pore structure in the rod. The effect of varying tortuosity 
on release profile of the protein from scaffold was derived from Equation 4.6 and plotted in 
Figure 4.4(b). The trend of slower release with the increasing drying time is in accordance 
the simulated release profile, where the protein release rate was decreased with increasing 
of tortuosity. The BSA distributed in the interstitial pace of particle network has to take 
longer path in order to diffuse into the surrounding medium. 
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Figure 4.4.  (a) The effect of drying time on BSA release profile; (b) simulated protein 
release profile from scaffold at various tortuosity, where Dp (about 3.40×10-8 cm/s) was 
obtained from fitting of experimental data. 
As the latex particles comprising the matrix of the polymer rod are impermeable to the 
proteins, the protein transport occurs exclusively within aqueous Pluronic hydrogel filled 
pores. Thus the protein diffusion behaviors in colloidal gel are mainly determined by 
protein diffusion coefficient in the Pluronic hydrogels. As shown in Figure 4.4(a), we 
observed that the release of BSA from colloidal gels is rapid and hydrogel in the scaffold 
rod has modest retardation effect on the protein diffusion: more than 60% released within 6 
h in most cases. This result can be contributed to the larger mesh size of Pluronic hydrogel 
mesh size compare to the much smaller dimensions of protein molecules. Though the 
protein release behavior can be affected by the characteristics of the microporous structures, 
such as tortuosity and pore connectivity in the scaffold rod, these factors are difficult to 
control and may have adverse effect on scaffold structural and mechanical properties. 
Recently, the controlled release of protein from hydrophilic nanoparticles, especially 
chitosan nanoparticles, has received much attention in therapeutic delivery field.[104, 147, 148] 
A major advantage of these nanoparticles is that they are synthesized under extremely mild 
 
59
conditions and the protein bioactivity is usually maintained.[141] Besides, they provide a 
continuous release of protein for extended periods of time and the release profile can be 
readily modulated by molecular and formation parameters of particles. To extend the 
duration of protein release from the colloidal gel resulted scaffolds, protein was first 
encapsulated in chitosan nanoparticles and then admixed with colloidal gel to form a 
composite colloidal gel system for fabricating protein incorporated scaffolds. As the 
particle size of the synthesized chitosan nanoparticles is normally in the range of 50 to 300 
nm, which are relatively smaller than the size of acrylic latex particles that formed the 
microporous structure of the scaffold rods, the addition of chitosan nanoparticles into the 
colloidal gels has no significant effects on the drying and stiffen behaviors of the derived 
scaffold, which has also been confirmed experimentally. 
Figure 4.5 shows the BSA release profiles of the composite colloidal gel scaffolds 
with encapsulating chitosan of various MW. All the scaffolds exhibit two release phases, a 
rapid release over the first 5 hours followed by a slow release for up to 7 days. The first 
release phase could be contributed to the release of BSA that were lightly associated with 
chitosan molecules and located near the surface of the particles while the second phase 
might correspond to those BSA more efficiently entrapped and tightly bound to the 
chitosan particles. The BSA proteins release from composite scaffolds at a constant but 
different rate by varying chitosan MW. The higher the MW of the chitosan that made the 
nanoparticles, the faster the BSA release from the composite scaffold. Theses results 
indicate that it’s possible to modulate the release rate of composite scaffold by simply 
adjusting the chitosan MW. 
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Figure 4.5.  The BSA release profile of scaffold fabricated with colloidal gel-chitosan 
nanoparticles composite scaffolds with varying molecular weights of chitosan. 
4.3.3  Stability Testing 
The protein property is another important factor affects protein release behavior from 
the colloidal gel scaffold. Figure 4.6 shows the release profiles of PDGF-BB from both 
colloidal gel scaffolds and composite colloidal gel scaffolds. The result revealed that 
PDGF-BB could be persistently released for optimal therapeutic efficacy in tissue 
engineering applications. Compared to BSA, PDGF-BB exhibits a much slower and 
sustained profile when they directly incorporated in colloidal gels. PDGF-BB and BSA 
have a distinctive isoelectrical point (IEP): the IEP of BSA is about 4.9 while PDGF-BB 
has an IEP of 11.0, suggesting that electrostatic forces may play a role in the difference of 
their release behaviors. In neutral pH medium, the PDGF-BB become highly positively 
charged after hydration and has higher affinity to the Pluronic molecules. To diffuse out to 
the release medium, PDGF-BB must overcome more hindrance than BSA, which may 
account for the slower release.  
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The bioactivity of the released proteins from scaffold was assessed by assaying the 
chemotactic effectiveness of the released PDGF-BB growth factors, which is the indicator 
for the level of their bioactivity. The PDGF-BB incorporated scaffold was soaked in the 
medium. Samples were collected during the release period of day 2 to day 4 and then 
diluted to 10 ng/ml and 2ng/ml. The media soaked with bare scaffold alone were selected 
as the negative control. Standard PDGF-BB solutions of same concentration as samples 
were prepared as positive control. As shown in Figure 4.6, the number of migrated cells 
was charted at varying concentration of released PDGF-BB and standard solution. Higher 
degree of cell migration was observed from PDGF-BB solution in contrast to that from the 
negative control media. PDGF-BB release from colloidal gel and colloidal gel-chitosan 
nanoparticles composite exhibited almost the equivalent cell chemotaxis activity as 
compared to standard PDGF-BB at both the level of 2 ng/ml and 10 ng/ml. In addition, the 
result showed an increasing responsiveness of fibroblast cell to both released and standard 
PDGF at increasing concentration from 2 to 10 ng/ml. This found concentration dependent 
chemotaxis behavior is consistent to the previously finding.[145, 152] The result revealed that 
the released PDGF retains its original biological activity and the mild biocasting procedures 
exert trivial effect on PDGF stability.  
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Figure 4.6.  (a) Release profile of PDGF-BB loaded in colloidal gel scaffold and colloidal 
gel-nanoparticles composite scaffold. (b) Chemotactic activity of PDGF released from 
colloidal gel based scaffold. Chemotactic activity was determined as the amount of 
migrated cells. 
As the scaffold fabrication process described in this work simply rely on the 
rheological properties of the colloidal material and the ability of the latex particles to 
coalescence upon drying with the application of minimal heat (typ. < 37 oC), thus the 
encapsulated protein will have little chance to get denatured. Furthermore, the constitute of 
the colloidal gel, Pluronic F127, has a unique stabilization effect to protein structure, makes 
it capable of preserving polypeptide bioactivities in vitro and in vivo.[153] This factors may 
all contribute to the great biological benign properties of the process 
4.3.4  Spatial Control of Protein Release 
The additive nature of the process and unique self-supporting feature of the colloidal 
gel offers great promise for producing objects made of multiple materials or functionally 
graded materials with complex internal void.[154] It provides a superb platform to fabricate 
heterogeneous scaffolds for complex artificial tissues, which require the spatial and 
temporal delivery of the biochemical signals to guild tissue growth and maintain cell 
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organization. In a typical process as illustrated in Figure 4.7, the multi-material deposition 
system fitted on the consists multiple material reservoirs (Figure 4.7 (a)) which house 
colloidal gel material loaded with different growth factors and feed to a common orifice or 
individual orifices. First, the designed 3D model is converted to a series of slices and then 
the outline of each slice is filled with some combination of contouring and rastering to 
produce a written path, which is also assigned a material property derived value. The 
position and material information is written into an interchangeable XML file and output 
via a machine specific script files, telling the writing machine to set syringe moving speed, 
deposition rate, dispensing on-off and so on. By controlling the relative flow rates of the 
multiple material feeds, the composition of the extrudate can be easily varied. Using this 
approach, an arbitrary-shaped 3D tissue construct with linear or non-linear composition 
gradients can be fabricated.  
 
Figure 4.7.  (a) A multi-material deposition system fitted on the consists multiple material 
reservoirs. The heterogeneous scaffold can be fabricated with a typical information 
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system process: (b) establish a 3D model; (c) model slicing into multiple layers; (d) 
generate filling toolpaths; (e) simulated deposition with multiple materials.  
4.3.5 Artificial Lymph Node 
In this work, our endeavors have been focus on developing a tissue equivalent of 
lymph node (artificial lymph node) for drug and vaccine testing. As it is a gigantic 
challenge to fabricate tissue constructs that faithfully replicate the natural lymph node 
morphologically and capable of regulating the cellular behavior in the exact tissue 
hierarchy, we hypothesize that, by coaxing the lymphocytes to form the essential 
organization as in the living tissue, a functional equivalent of a lymph node could be 
accomplished that possess the equal tissue functions as the real lymph node. As exhibited 
in Figure 4.8, lymphoid tissues exhibit a unique histological structure or 3D architecture 
comprising of an assortment of functionally distinct zones.[155] Notably in the lymph node, 
the physical segregation of T and B lymphocytes zones is believed to facilitate the T-B cell 
migration and interaction, implying its significance in the mediation of the of lymphocytes 
interactions, maturation and migration, and finally a efficient immune reactivity.[156, 157] 
 
Figure 4.8.  (a) Histological section of the lymph node and (b) example histology of 
lymph node where B cells are stained blue and T cells brown. 
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Base on this assumption, the potential application of fabricated scaffolds for lymphoid 
tissue equivalent was investigated. As the cell signal communicating proteins can be 
readily integrated to colloidal gel material and controlled release without loss of bioactivity, 
it become viable to incorporate appropriate cytokines in the scaffold and strategically 
controlled release in geospatial variation mode to stimulate T and B cells form the T and B 
cell zone organization. Among large families of chemokines and chemotactic agents that 
regulate the migratory pathways of immune cells, CXCL13 for localizing B cells and 
CCL19 and CCL21 for attracting T and dendritic cells, are believed be a key to maintain 
the highly motile T and B lymphocytes within the distinctive zones. For the proof of 
concept demonstration (Figure 4.9), a heterogeneous scaffold was assembled with one 
material incorporated with CXCL13 for localizing B cells and the other one integrated with 
CCL19 and CCL21 for attracting T and dendritic cells. The prototyped scaffold has a 
unique checkerboard pattern to mimic the tissue architecture and extracellular signaling 
environment seen by lymphocytes. In the design, every unit includes eight interconnected 
pores in the dimension of about 150 μm and is surrounded with straight channels, which 
may help facilitate the nutrient transportation and cell migration, ultimately simulating T 
and B cell organization sufficiently to achieve appropriate tissue functions.  
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Figure 4.9.  Heterogeneous scaffold deposited with perpendicular serpentine pattern for 
artificial lymph node. (a) Photo of freshly deposited scaffold and (b) microscopic picture 
showing segregated zones with distinctive colors.  
Based on this multiple cytokine release scaffold that mimic the local environment of 
the lymph node, the formation of artificial lymph node will finally promising. Nevertheless, 
the more experiments (i.e. investigation of appropriate cytokine loading effect on cell 
localization) need to be done to further prove the viability of this scheme. 
4.4 Conclusions  
In this work, strategies for incorporation of proteins into colloidal gel based scaffold 
and subsequently releasing in a temporally and spatially controlled fashion have been 
developed. In the first method, the model protein BSA was admixed directly with colloidal 
gels such that they can be dispersed in the interstices of colloidal particle networks. 
However the protein release from resulting scaffold was rapid and difficult to control. To 
achieve a sustained release system, the protein was encapsulated in chitosan nanoparticles 
first and then dispersed in colloidal gels. The resulting composite colloidal gel scaffold was 
shown extended the duration of protein release to more than one week and the release rate 
 
67
can be controlled by adjusting molecular weight of chitosan molecules. Additionally, the 
protein retains its bioactivity after release, which is confirmed by cell chemotaxis assay. In 
this work, the approach for spatial control of protein release was also demonstrated. Based 
on this platform, a checkerboard patterned heterogeneous scaffold was designed and 
fabricated to demonstrate the possibility for forming an artificial lymph node.   
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Chapter 5 Conclusion and Recommendations 
 
5.1 Conclusions 
The following is a summary of the tasks that were performed and the conclusion of 
the studies conducted. 
1. The colloidal gels were formulated by combining polyacrylate latex particles with 
Pluronic F127 copolymers as binder, which are conjectured to adsorb such that the 
hydrophobic PPO section in the middle anchors on the particle surface whereas the 
solvated PEO blocks extend out into the solution. With appropriate formulation parameters, 
the extending PEO strands from neighboring particles become crosslinked through 
hydrogen bonding and finally lead to colloidal gels. 
2. The viscosity and elastic modulus of colloidal gel are a function of Pluronic volume 
fraction. At φPluronic < 0.05, the colloidal gels displayed only weak shear thinning and a 
negligible yield stress while, at φPluronic > 0.06, the colloidal gels strengthened and exhibited 
a significant pseudoplastic and thioxtropic behavior, which can be described by the 
Hershel-Bulkley model. 
3. The viscoelastic and rheological properties of colloidal gel are also dependent on 
solid loading. ηapp and G' increase with increasing of φparticle for the colloidal gels,  
especially the yield stress increases more than 10 fold with φparticle from 0.50 to 0.55. With 
φparticle = 0.62, the system approaches the maximum solids loading and processing become 
extremely difficult. 
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4. The colloidal gels initiated by physical association become temporarily disrupted 
when subject to high shear conditions such as deposition and so as to exhibit a shear 
thinning rheology. Upon returning to a quiescent state, the colloidal network is re-
established rapidly and the material returns to the gel state. This unique feature of 
colloidal gels is well suited to fulfill the requirements of flow through a deposition nozzle 
and rapidly “set” to maintain the shape of the deposited structure. 
5. Scaffolds with periodic lattice structure of tetragonal and cylindrical symmetry 
were assembled from colloidal gel based materials. The scaffold rods maintained a circular 
cross section and spanned the gaps with minimal deflection after deposition. The feature 
size of the process is mainly dependent on material properties and nozzle size, normally in 
the range of 100~200 µm. The porous structure of scaffolds can be controlled by varying 
deposition parameters. Scaffolds with a porosity from 0.23 to 0.86 have been successfully 
fabricated. 
6. GFP transfected quail mesodermal stem cell (QCE6) was seeded into the tissue 
scaffolds. During the culture, cells were seen to attach onto the scaffold surface, actively 
grow in the pore structure, and finally occupy the entire scaffold in three dimensions. The 
cytotoxicity of the scaffold materials was assessed by GFP expression of the QCE6 cell in 
scaffold. The result demonstrates the ability to culture cells on the scaffold while 
maintaining viability of the cells over the 14-day period, suggesting minimal cytotoxicity 
of the scaffold material to quail stem cell line. 
7. The solidification of colloidal gel based scaffolds is governed by the glass transition 
temperature (Tg) of the polymer particles in the contact zone. If process temperature (Tp) >> 
Tg , the colloidal gels will readily to sinter and form a coherent and continuous solid. 
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8. As the particle coalescence toward a continuous solid was arrested after drying, the 
derived scaffolds have a secondary structure formed by the interstices of aggregated or 
sintered colloidal particle networks. This presents us an interesting potential for the 
incorporation of proteins in scaffold where protein can loaded by dispersing in the 
interstitial space of the latex particle network. 
9. The cross sections of the polymer scaffold incorporated with Texas red labeled 
BSA were examined by light and confocal microscopy and shown the BSA is uniformly 
distributed throughout the diameter in scaffold rod with no locally aggregation and radius 
compositional difference. This phenomenon was attributed to the trivial mobility resulting 
from large molecular weight of the protein. 
10. BSA release behavior from colloidal gel derived scaffolds exhibited a strong 
dependence on post processing conditions, such as drying time. The protein release rate of 
scaffold decreased notably with longer drying. This phenomenon was attributed to particle 
packing and scaffold densification and the resulting extra tortuosity of the inner pore 
structure in the rod. 
11. In the cases that BSA is incorporated into scaffolds with original form, the rapid 
protein release was observed, suggesting that Pluronic F217 hydrogel in the scaffold rod 
has minor retardation effect on the protein diffusion. This result can be contributed to the 
larger mesh size of hydrogel mesh size compare to the much smaller dimensions of protein 
molecules.   
12. To extend the duration of protein release from the colloidal gel resulted scaffolds, a 
colloidal gel-nanoparticle composite system was implemented by encapsulating protein in 
chitosan nanoparticles and then admixing nanoparticles with colloidal gels. The BSA 
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proteins release from composite scaffolds at a sustained profile and constant rate. Also the 
protein rate is dependent on chitosan MW. The higher the MW of the chitosan that made 
the nanoparticles, the faster was the BSA release from the composite scaffold. 
13. To investigate the stability of the incorporated proteins, the chemotaxis behavior of 
growth factors was chosen as the indicator for the level of their bioactivity. PDGF-BB 
release from colloidal gel and colloidal gel-chitosan nanoparticles composite exhibited 
almost the equivalent cell chemotaxis activity as compared to standard PDGF-BB at both 
the level of 2ng/ml and 10 ng/ml. The result revealed that the released PDGF retains its 
original biological activity and the mild biocasting procedures exert trivial effect on PDGF 
stability. 
14. The additive nature of the process and unique self-supporting feature of the 
colloidal gel offers great promise for producing objects made of multiple materials or 
functionally graded materials with complex internal void. By controlling the relative flow 
rates of the multiple material feeds, the composition of the extrudate can be easily varied. 
Using this approach, an arbitrary-shaped 3D tissue construct with linear or non-linear 
composition gradients can be fabricated 
15. The potential application of fabricated scaffolds for lymphoid tissue equivalent was 
investigated. As the physical segregation of T and B lymphocytes zones is believed to have 
its significance for the efficient immune reactivity, a heterogeneous scaffold was assembled 
with one material incorporated with CXCL13 for localizing B cells and the other one 
integrated with CCL19 and CCL21 for attracting T and dendritic cells. 
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5.2 Recommendations 
It is strongly encouraged that continued investigation need to be done to further prove 
the viability of this scheme. 
1. Formulation of colloidal gels for better mechanical and biological properties using 
different latex polymer and binders. Develop polymer nano/micro particle manufacturing 
techniques to fabricate various candidate latex polymers into particle with desirable size 
and size distributions. Evaluate various physical associative polymers as binder, such as 
collagen, chitosan and agar, and develop different gelling methods with respect to various 
binder properties. 
2. Evaluate the interaction between colloidal gels and seeded cells. Screen materials 
by performing the lymphocyte culture in the scaffold for excellent biocompatibility and 
minimal immunogenicity.  
3. Incorporate appropriate cytokines in the scaffolds and strategically controlled 
release in geospatial variation mode to stimulate T and B cells form the T/B cell zone 
organization. Investigate the appropriate cytokine loading effect on cell localization. 
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